Protein kinase C‐α in prostate cancer

This publication has 29 references indexed in Scilit:

• Smart Weapons Prove Tough to Design
  Science, 2002
• Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer
  Prostate Cancer and Prostatic Diseases, 2002
• Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer
  Seminars in Oncology, 2001
• Delineation of prognostic biomarkers in prostate cancer
  Nature, 2001
• Upregulation of p21WAF1/CIP1 leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1
  Oncogene, 2001
• Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
  Journal of Gastrointestinal Surgery, 2000
• Protein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer
  The American Journal of Pathology, 1999
• The Protein Kinase C Activator, Phorbol Ester, Elicits Disparate Functional Responses in Androgen-Sensitive and Androgen-Independent Human Prostatic Cancer Cells
  Biochemical and Biophysical Research Communications, 1998
• Transforming Growth Factor- 1 Inhibits Membrane Association of Protein Kinase C in a Human Prostate Cancer Cell Line, PC3
  Endocrinology, 1997
• The molecular heterogeneity of protein kinase C and its implications for cellular regulation
  Nature, 1988